01-2331. National Institute of Arthritis and Musculoskeletal and Skin Disease; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council.

    The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign Start Printed Page 7922language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Arthritis and Musculoskeletal and Skin Diseases Advisory Council.

    Date: February 15, 2001.

    Open: 8:30 a.m. to 2 p.m.

    Agenda: The meeting will be open to the public to discuss administrative details relating to Council business and special reports.

    Place: 31 Center Drive, Bldg., 31; Conference Room 6, Bethesda, MD 20892.

    Closed: 2 p.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: 31 Center Drive, Bldg., 31; Conference Room 6, Bethesda, MD 20892.

    Contact Person: Steven J. Hausman, PhD, Deputy Director, NIAMS/NIH, Bldg. 31, Room 4C-32, 31 Center Dr, MSC 2350, Bethesda, MD 20892-2350.

    Start Signature

    (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS)

    Dated: January 18, 2001.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 01-2331 Filed 1-25-01; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
2/15/2001
Published:
01/26/2001
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
01-2331
Dates:
February 15, 2001.
Pages:
7921-7922 (2 pages)
PDF File:
01-2331.pdf